Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genetic Technologies Limited (GNTLF)
:GNTLF
Holding GNTLF?
Track your performance easily
GNTLF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.00 - $1.00
Previous CloseN/A
Volume100.00
Average Volume (3M)15.00
Market Cap
$5.85M
Enterprise Value$9.77M
Total Cash (Recent Filing)$10.99M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta16.66
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume15
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.63
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.67
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.03
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genetic Technologies News
PremiumCompany Announcements
Genetic Technologies to Divest DTC Businesses in Strategic Sale
PremiumCompany Announcements
Genetic Technologies Sells geneType Business to Rhythm Biosciences
PremiumCompany Announcements
Rhythm Biosciences Expands with Genetype Acquisition
PremiumCompany Announcements
Genetic Technologies Defers Reports Amid AdministrationPremiumCompany Announcements
Genetic Technologies Halts Offers, Returns Funds Amid Compliance Scrutiny
PremiumCompany Announcements
Genetic Technologies Cancels Entitlement Offer Plans
PremiumCompany Announcements
Genetic Technologies Withdraws Offer Amid Strategic Review
PremiumCompany Announcements
Genetic Technologies Enters Voluntary AdministrationGNTLF FAQ
What was Genetic Technologies Limited’s price range in the past 12 months?
Genetic Technologies Limited lowest stock price was $0.00 and its highest was $1.00 in the past 12 months.
What is Genetic Technologies Limited’s market cap?
Genetic Technologies Limited’s market cap is $5.85M.
When is Genetic Technologies Limited’s upcoming earnings report date?
Genetic Technologies Limited’s upcoming earnings report date is Feb 26, 2025 which is in 38 days.
How were Genetic Technologies Limited’s earnings last quarter?
Genetic Technologies Limited released its earnings results on Aug 29, 2024. The company reported -$0.026 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.026.
Is Genetic Technologies Limited overvalued?
According to Wall Street analysts Genetic Technologies Limited’s price is currently Overvalued.
Does Genetic Technologies Limited pay dividends?
Genetic Technologies Limited does not currently pay dividends.
What is Genetic Technologies Limited’s EPS estimate?
Genetic Technologies Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genetic Technologies Limited have?
Currently, no data Available
What happened to Genetic Technologies Limited’s price movement after its last earnings report?
Genetic Technologies Limited reported an EPS of -$0.026 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Genetic Technologies Limited?
Currently, no hedge funds are holding shares in GNTLF
---
Genetic Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
GNTLF Sentiment 70%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-181.97%
Trailing 12-Months
Asset Growth
-58.22%
Trailing 12-Months
Company Description
Genetic Technologies Limited
Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
---
Northwest Biotherapeutics
―
Oncolytics Biotech
―
CytoDyn
―
BioNano Genomics
―
Advaxis
―
Crispr Therapeutics AG
―
---